Rol de la terapia de resincronización ventricular en el tratamiento de pacientes con insuficiencia cardiaca avanzada
Asenjo G., René; Cereceda B., Mauricio.
Cardiol. clín
; 22(2): 88-93, 2006. ilus, tab
Artículo en Español | LILACS | ID: lil-452451
Documentos relacionados
[Resynchronization therapy of heart failure].
Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.
Efficacy of antitachycardia pacing for electrical storms in patients with implantable defibrillators.
Temporal association between drops in thoracic impedance and malignant ventricular arrhythmia: A longitudinal analysis of remote monitoring trends.
Antitachycardia pacing at the His bundle is safer than conventional right ventricular antitachycardia pacing in a canine myocardial ischemic injury model.
The electrocardiographic interpretation of ventricular pacing suppression algorithms in the pacemaker.
Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators.
[Device therapy in chronic heart failure].
Modified therapy for heart failure extends life. For some people with heart failure, a combination of two existing treatments lessens symptoms and delays death.